title: [Delay in the introduction of treatment modalities for neuroendocrine tumors in Japan].
abstract: The incidence of pancreatic-intestinal neuroendocrine tumors is rapidly increasing worldwide, and intensive research has been carried out for the standardization of its treatment. In Japan, a few diagnostic and treatment modalities including somatostatin receptor scintigraphy(SRS)have not been approved by the government. Therefore, we intend to improve this situation as soon as possible.
authors.affiliation: Kansai Electric Power Hospital, Endocrine Tumor Center, Osaka, Japan.
authors.forename: Masayuki
authors.initials: M
authors.lastname: Imamura
mesh_terms: D003131:Combined Modality Therapy; D006801:Humans; D007564:Japan; D058990:Molecular Targeted Therapy; D018358:Neuroendocrine Tumors / Q000175:diagnosis / Q000378:metabolism / Q000628:therapy*; D017410:Practice Guidelines as Topic